Antithrombotic effects of ticlopidine, acetylsalicylic acid and dipyridamole in vascular shunt model in rats

This publication has 18 references indexed in Scilit:

• The Influence of Red Blood Cells on the Effects of Aspirin or Sulphinpyrazone on Platelet Adherence to Damaged Rabbit Aorta
  British Journal of Haematology, 1979
• DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLIN
  The Lancet, 1978
• Clinical Pharmacology of a New Antithrombotic Agent, Ticlo
  Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1978
• The AMIS Trial: Can Aspirin Prevent Heart Attacks?
  Science, 1977
• HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
  The Lancet, 1977
• An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
  Nature, 1976
• The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosis.
  Circulation, 1975
• Induction of experimental arterial occlusive thrombi in rats
  Atherosclerosis, 1973
• EFFECTS OF SALICYLATES ON HUMAN PLATELETS
  The Lancet, 1968
• Reduction of clotting in Scribner shunts by long-term anticoagulation.
  BMJ, 1967